PureTech Health (PRTC) Competitors $18.43 +1.02 (+5.83%) As of 09:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTC vs. IRON, IDYA, INDV, EWTX, JANX, EVO, IMCR, MESO, ADPT, and VERAShould you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Disc Medicine (IRON), IDEAYA Biosciences (IDYA), Indivior (INDV), Edgewise Therapeutics (EWTX), Janux Therapeutics (JANX), Evotec (EVO), Immunocore (IMCR), Mesoblast (MESO), Adaptive Biotechnologies (ADPT), and Vera Therapeutics (VERA). These companies are all part of the "pharmaceutical products" industry. PureTech Health vs. Disc Medicine IDEAYA Biosciences Indivior Edgewise Therapeutics Janux Therapeutics Evotec Immunocore Mesoblast Adaptive Biotechnologies Vera Therapeutics Disc Medicine (NASDAQ:IRON) and PureTech Health (NASDAQ:PRTC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, community ranking, profitability, earnings, analyst recommendations, valuation and risk. Is IRON or PRTC more profitable? PureTech Health's return on equity of 0.00% beat Disc Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Disc MedicineN/A -25.24% -23.96% PureTech Health N/A N/A N/A Does the MarketBeat Community favor IRON or PRTC? Disc Medicine received 50 more outperform votes than PureTech Health when rated by MarketBeat users. Likewise, 86.76% of users gave Disc Medicine an outperform vote while only 45.00% of users gave PureTech Health an outperform vote. CompanyUnderperformOutperformDisc MedicineOutperform Votes5986.76% Underperform Votes913.24%PureTech HealthOutperform Votes945.00% Underperform Votes1155.00% Which has higher earnings and valuation, IRON or PRTC? PureTech Health has higher revenue and earnings than Disc Medicine. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDisc MedicineN/AN/A-$76.43M-$3.92-12.61PureTech Health$4.32M102.62-$65.70MN/AN/A Which has more risk & volatility, IRON or PRTC? Disc Medicine has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Does the media refer more to IRON or PRTC? In the previous week, Disc Medicine had 7 more articles in the media than PureTech Health. MarketBeat recorded 7 mentions for Disc Medicine and 0 mentions for PureTech Health. Disc Medicine's average media sentiment score of 0.65 beat PureTech Health's score of 0.00 indicating that Disc Medicine is being referred to more favorably in the media. Company Overall Sentiment Disc Medicine Positive PureTech Health Neutral Do analysts rate IRON or PRTC? Disc Medicine presently has a consensus target price of $98.80, indicating a potential upside of 99.80%. PureTech Health has a consensus target price of $45.00, indicating a potential upside of 144.10%. Given PureTech Health's stronger consensus rating and higher possible upside, analysts clearly believe PureTech Health is more favorable than Disc Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Do insiders and institutionals have more ownership in IRON or PRTC? 83.7% of Disc Medicine shares are held by institutional investors. Comparatively, 0.0% of PureTech Health shares are held by institutional investors. 4.2% of Disc Medicine shares are held by company insiders. Comparatively, 5.3% of PureTech Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryPureTech Health beats Disc Medicine on 8 of the 14 factors compared between the two stocks. Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTC vs. The Competition Export to ExcelMetricPureTech HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$446.15M$6.54B$5.42B$8.48BDividend YieldN/A2.66%5.22%4.11%P/E RatioN/A9.1426.7820.05Price / Sales102.62255.59395.49116.44Price / CashN/A65.8538.2534.62Price / Book1.096.546.874.61Net Income-$65.70M$143.51M$3.22B$248.19M7 Day Performance12.03%5.60%5.69%2.56%1 Month Performance10.82%10.06%12.66%16.18%1 Year Performance-37.51%-0.86%18.01%8.16% PureTech Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTCPureTech Health1.5426 of 5 stars$18.44+5.8%$45.00+144.1%-39.3%$446.15M$4.32M0.00100Gap UpIRONDisc Medicine2.9064 of 5 stars$46.61+5.4%$98.80+112.0%+54.7%$1.61BN/A-11.7130IDYAIDEAYA Biosciences3.8136 of 5 stars$18.35+5.3%$53.58+192.0%-51.3%$1.61B$7M-5.5680Gap UpINDVIndivior3.3343 of 5 stars$11.34+2.3%$15.00+32.3%-33.1%$1.56B$1.17B-32.401,164News CoveragePositive NewsGap DownEWTXEdgewise Therapeutics2.9354 of 5 stars$14.82+1.6%$40.22+171.4%-20.8%$1.55BN/A-9.8860Positive NewsJANXJanux Therapeutics2.7916 of 5 stars$26.06+2.0%$95.25+265.5%-47.1%$1.54B$10.59M-22.2730Positive NewsEVOEvotec1.5296 of 5 stars$4.17-3.0%$5.93+42.3%-21.9%$1.48B$788.22M0.004,200Positive NewsIMCRImmunocore2.9533 of 5 stars$29.54+4.0%$58.13+96.8%-39.1%$1.48B$310.20M-31.09320Positive NewsMESOMesoblast1.8699 of 5 stars$11.35+3.5%$18.00+58.6%+57.9%$1.45B$5.67M0.0080Gap UpADPTAdaptive Biotechnologies3.6065 of 5 stars$9.51+5.3%$9.83+3.4%+160.7%$1.44B$189.53M-8.72790News CoveragePositive NewsVERAVera Therapeutics3.4019 of 5 stars$22.49+3.6%$63.33+181.6%-48.2%$1.43BN/A-8.6240Positive News Related Companies and Tools Related Companies IRON Alternatives IDYA Alternatives INDV Alternatives EWTX Alternatives JANX Alternatives EVO Alternatives IMCR Alternatives MESO Alternatives ADPT Alternatives VERA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTC) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRTC Stock Free PRTC Stock Alerts